RCAN1-mediated calcineurin inhibition as a target for cancer therapy

Cancer is the leading cause of mortality worldwide. Regulator of calcineurin 1 (RCAN1), as a patent endogenous inhibitor of calcineurin, plays crucial roles in the pathogenesis of cancers. Except for hypopharyngeal and laryngopharynx cancer, high expression of RCAN1 inhibits tumor progression. Molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lao, Mengyi, Zhang, Xiaozhen, Yang, Hanshen, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206313/
https://www.ncbi.nlm.nih.gov/pubmed/35717152
http://dx.doi.org/10.1186/s10020-022-00492-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206313/
https://www.ncbi.nlm.nih.gov/pubmed/35717152
http://dx.doi.org/10.1186/s10020-022-00492-7

Ejemplares similares